Protect Your Organisation, HCPs, Patients & Stakeholders, Proactively Identify New Threats & Dangers With Potential To Disrupt & Effectively Navigate Constantly Changing Legislation For
08.30 Registration, Informal Networking & GIC Opening Remarks
09.10 Morning Chair’s Opening Remarks
Ben Kaye-Smith, Head Ethics Risk & Compliance Europe, Novartis Innovative Medicines
09.20 The Evolving Privacy Landscape: Regulatory Trends & Business Developments That Transform The Role Of Privacy Professionals Globally
Antonios Roussos, Head of Global E&C Data Privacy & Group DPO, Astellas Pharma Inc
PANEL
Q&A
09.40 Incorporate The Latest AI, Automation & Technological Advances To Streamline Business & Healthcare Practices Whilst Determining & Mitigating Potential Risks
Vyomesh Patel, Area OEC Director (Aesthetics)-Western Europe and Canada, AbbVie
Lizanne Pistorius, Senior Manager Global Patient Safety Operations, QMS & Risk Management, Nestlé Health Science/Aimmune Therapeutics
Béatrice Nihoul, Senior Director, Global Compliance & Ethics, Galapagos GmbH
Charles-Edouard Castaigne, Head of Internal Audit for Global Business Units, Sanofi
10.10 Bonus Session; Live AI compliance demonstration
Marcos Richardson, CEO, Zen Intelligence
10.40 Morning Refreshment Break With Informal Networking
11.10 Boost Resilience, Flexibility & Agility In Your Pharma & Life Sciences Organisational Practices By Exploring Cutting-Edge Approaches To Gauging New Risks
Dr Emilio Rubio, Head ERC SIR, Sandoz
11.30 Assess Modern Supply Chain Challenges & Complexities To Drive Transparency, Compliance & Ethics While Retaining Efficiencies & Productivity
11.50 Maintain Integrity & Transparency At Every Level Of Business With Clear Codes Of Ethical Conduct That Put Honesty First
Enrique Grande, Head of Ethics & Compliance Iberia, Takeda
Ben Kaye-Smith, Head Ethics Risk & Compliance Europe, Novartis Innovative Medicines
Alexander Moss, Regional Investigations Lead, Worldwide Compliance & Business Ethics, Amgen
Teresa Rosa, CSL Regional Ethics and Compliance Officer Europe, Sr. Director, CSL
Kyriaki (Kiki) Merakli, Region Head, Ethics, Risk & Compliance, Novartis Pharma
12.20 Protect Your Pharma & Life Sciences Organisation From Financial & Reputational Harm, Ensure Patient Safety Is At The Forefront Of Your Practices & Best Prepare To Navigate Constantly Changing Legislation
Lizanne Pistorius, Senior Manager Global Patient Safety Operations, QMS & Risk Management, Nestlé Health Science/Aimmune Therapeutics
12.40 Lunch & Informal Networking For Speakers, Delegates & Partners
13.10 Informal Breakout Discussions
A) HCP Engagement & Interaction
B) Anti-Bribery & Anti-Corruption
C) Patient Safety & Collaboration
D) Measuring The Effectiveness Of Compliance Programmes
Rob Grover, Senior Director, Strategy & Continuous Improvement, Astellas Pharma Inc.
13.40 Afternoon Co-Chairs’ Opening Remarks
Bennett Lau, Compliance Officer Policy & Procedures EUROPE, Daiichi Sankyo GmbH
Kyriaki (Kiki) Merakli, Region Head, Ethics, Risk & Compliance, Novartis Pharma
13.50 Session 1: Deep Dive & Evaluate Your Third-Party Relationships To Ensure Clear, Credible & Compliant Communication From Inside & Outside Your Business & Stay Protected On All Sides
Christian Mühl, Head Ethics & Compliance, Member Global Leadership Team, Partner & Emerging Markets, Alnylam Inc
14.10 Session 2: Deep Dive & Evaluate Your Third-Party Relationships To Ensure Clear, Credible & Compliant Communication From Inside & Outside Your Business & Stay Protected On All Sides
Teodora Alexandrova, Associate Director ECP (Ethics, Compliance, Privacy) EMENA – Controls and Processes, Accord Healthcare
Chris Key, Senior Director – Compliance, Ethics and Privacy Europe and MENA, Accord Healthcare
14.30 Stay Safe & Secure In The Fast-Paced, Ever-Evolving World Of Cyber Attacks By Identifying & Preparing For Potential Dangers, Implementing The Latest Security Strategies & Always Keeping Two Steps Ahead
Olawale Alimi, Director, Data Policy (R&D Data Risk and Compliance), AstraZeneca
14.50 Bonus Session; Reserved For Exclusive Conference Partner
15:20 Afternoon Refreshment Break With Informal Networking
15.50 Determine The Threats & Dangers From The Current Geopolitical Situations, Track The Global Market & Anticipate The Next Developments Set To Disrupt Risk & Compliance In Pharma & Life Sciences
16.10 Enhance Sustainability Practices, Meet Critical Expectations & Maximise Practical Applications To Seamlessly Embed Into Existing Strategies For Maximum Impact
Stephanie Wingrove, VP & Global Head of Ethics and Compliance, Galapagos
PANEL
Q&A
16.30 Identify The Latest Threats To The Sector, Assess Possible Business Impact & Forecast Future Developments To Protect Your Business From Risk & Compliance Risks
Tamara Chisholm, Senior Legal Director, Global Compliance, Gilead Sciences
Phil Brown, Director, Regulatory & Compliance, ABHI
Floriane Solere, Compliance Senior Manager, Amgen
Barbara Badoino, Global Head Risk & Resilience, Novartis
17.00 Afternoon Co-Chairs’ Closing Remarks & Official Close Of Conference
The Risk & Compliance, Pharma & Life Sciences Conference is Organised By Global Insight Conferences. Copyright © 2023 Global Insight Conferences Ltd.